156 related articles for article (PubMed ID: 2941768)
21. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat.
Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C
Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587
[TBL] [Abstract][Full Text] [Related]
22. Substance P and substance K in the rat hypothalamus following monosodium glutamate lesions of the arcuate nucleus.
Jessop DS; Chowdrey HS; Biswas S; Lightman SL
Neuropeptides; 1991 Mar; 18(3):165-70. PubMed ID: 1712432
[TBL] [Abstract][Full Text] [Related]
23. Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus.
Sartin JL; Lamperti AA; Kemppainen RJ
Endocr Res; 1985; 11(3-4):145-55. PubMed ID: 3914419
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse.
Lorden JF; Caudle A
Neurobehav Toxicol Teratol; 1986; 8(5):509-19. PubMed ID: 3785512
[TBL] [Abstract][Full Text] [Related]
25. Neonatal administration of monosodium glutamate prevents the development of ethanol- but not psychostimulant-induced sensitization: a putative role of the arcuate nucleus.
Miquel M; Font L; Sanchis-Segura C; Aragon CM
Eur J Neurosci; 2003 May; 17(10):2163-70. PubMed ID: 12786983
[TBL] [Abstract][Full Text] [Related]
26. Studies on brain lesions after administration of monosodium L-glutamate to mice. II. Absence of brain damage following administration of monosodium L-glutamate in the diet.
Takasaki Y
Toxicology; 1978 Apr; 9(4):307-18. PubMed ID: 663940
[TBL] [Abstract][Full Text] [Related]
27. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats.
Corder R; Saudan P; Mazlan M; McLean C; Gaillard RC
Neuroendocrinology; 1990 Jan; 51(1):85-92. PubMed ID: 2106092
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
29. Neonatal exposure to monosodium glutamate alters the neurobehavioral performance of adult rats.
Squibb RE; Tilson HA; Meyer OA; Lamartiniere CA
Neurotoxicology; 1981 Nov; 2(3):471-84. PubMed ID: 7199686
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of central administration of beta-endorphin in rats receiving neonatal injection of monosodium glutamate.
Wong TM; Lee AY; Chan RK
Clin Exp Pharmacol Physiol; 1989 Jan; 16(1):19-24. PubMed ID: 2523263
[TBL] [Abstract][Full Text] [Related]
31. Mealing and related hormone release suppress hypothalamic lesions of neonatal mice by L-glutamate.
Torii K; Takasaki Y
Brain Res Bull; 1987 Apr; 18(4):547-54. PubMed ID: 2886196
[TBL] [Abstract][Full Text] [Related]
32. Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult.
Dawson R; Callahan MF; Annau Z
Pharmacology; 1986; 32(1):25-37. PubMed ID: 2418449
[TBL] [Abstract][Full Text] [Related]
33. Studies on brain lesion by administration of monosodium L-glutamate to mice. I. Brain lesions in infant mice caused by administration of monosodium L-glutamate.
Takasaki Y
Toxicology; 1978 Apr; 9(4):293-305. PubMed ID: 663939
[TBL] [Abstract][Full Text] [Related]
34. Tuberohypophyseal and tuberoinfundibular dopamine systems exhibit differential sensitivity to neonatal monosodium glutamate treatment.
Dawson R; Valdes JJ; Annau Z
Pharmacology; 1985; 31(1):17-23. PubMed ID: 2862648
[TBL] [Abstract][Full Text] [Related]
35. [Effects of beta-endorphin on glutamate neurotoxicity].
Gao J; Zhu L; Zhao X; Zhang Z
Yao Xue Xue Bao; 1998; 33(3):161-4. PubMed ID: 11938958
[TBL] [Abstract][Full Text] [Related]
36. Prevention of reflex natriuresis after acute unilateral nephrectomy by neonatal administration of MSG.
Lin SY; Wiedemann E; Deschepper CF; Alper RH; Humphreys MH
Am J Physiol; 1987 Feb; 252(2 Pt 2):F276-82. PubMed ID: 3812742
[TBL] [Abstract][Full Text] [Related]
37. Hypothalamic morphology following ingestion of aspartame or MSG in the neonatal rodent and primate: a preliminary report.
Reynolds WA; Butler V; Lemkey-Johnston N
J Toxicol Environ Health; 1976 Nov; 2(2):471-80. PubMed ID: 827619
[TBL] [Abstract][Full Text] [Related]
38. [Effects of neonatal administration of monosodium glutamate on four neuropeptide concentrations in the rat brain].
Hashigami Y
Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):79-90. PubMed ID: 2568279
[TBL] [Abstract][Full Text] [Related]
39. Sex-related alterations in hypothalamic tyrosine hydroxylase after neonatal monosodium glutamate treatment.
Arbogast LA; Voogt JL
Neuroendocrinology; 1990 Nov; 52(5):460-7. PubMed ID: 1980722
[TBL] [Abstract][Full Text] [Related]
40. Effect of water restriction on the development of hypothalamic lesions in weanling rodents given MSG. I. Drinking behaviour and physiological parameters in mice (Mus musculus).
Torii K; Takasaki Y
Toxicol Lett; 1983 May; 16(3-4):175-94. PubMed ID: 6857715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
